Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (181-190 of 415) with videos related to

Pageof 42
Sort By:
AIDS Research and Therapy|August 15, 2014
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityYassine Bouatou, Caroline Flora Samer, Kuntheavy Roseline Ing Lorenzini, et al.
AIDS (London, England)|March 9, 2012
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavirJim Young, Juliane Schäfer, Christoph A Fux, et al.
AIDS Care|January 6, 2017
High prevalence of physical inactivity among patients from the Swiss HIV Cohort StudyJuliane Schäfer, Jim Young, Alexandra Calmy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2013
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)Reto Nüesch, Qing Wang, Luigia Elzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort StudyHelen Kovari, Alexandra Calmy, Thanh Doco-Lecompte, et al.
Clinical and Translational Science|June 16, 2022
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialKenza Abouir, Pauline Gosselin, Stéphane Guerrier, et al.
AIDS (London, England)|November 8, 2017
Benefits and risks of rapid initiation of antiretroviral therapyNathan Ford, Chantal Migone, Alexandra Calmy, et al.
Journal of the International AIDS Society|September 27, 2012
Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer, Alexandra Calmy, Pedro Cahn, et al.
Kidney International Reports|September 11, 2018
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID StudyYassine Bouatou, Angele Gayet Ageron, Enos Bernasconi, et al.
European Heart Journal|March 29, 2018
Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative personsPhilip E Tarr, Bruno Ledergerber, Alexandra Calmy, et al.
Pageof 42

Showing results (181-190 of 415) with videos related to

Sort By:
Pageof 42
AIDS Research and Therapy|August 15, 2014
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityYassine Bouatou, Caroline Flora Samer, Kuntheavy Roseline Ing Lorenzini, et al.
AIDS (London, England)|March 9, 2012
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavirJim Young, Juliane Schäfer, Christoph A Fux, et al.
AIDS Care|January 6, 2017
High prevalence of physical inactivity among patients from the Swiss HIV Cohort StudyJuliane Schäfer, Jim Young, Alexandra Calmy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2013
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)Reto Nüesch, Qing Wang, Luigia Elzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort StudyHelen Kovari, Alexandra Calmy, Thanh Doco-Lecompte, et al.
Clinical and Translational Science|June 16, 2022
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialKenza Abouir, Pauline Gosselin, Stéphane Guerrier, et al.
AIDS (London, England)|November 8, 2017
Benefits and risks of rapid initiation of antiretroviral therapyNathan Ford, Chantal Migone, Alexandra Calmy, et al.
Journal of the International AIDS Society|September 27, 2012
Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer, Alexandra Calmy, Pedro Cahn, et al.
Kidney International Reports|September 11, 2018
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID StudyYassine Bouatou, Angele Gayet Ageron, Enos Bernasconi, et al.
European Heart Journal|March 29, 2018
Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative personsPhilip E Tarr, Bruno Ledergerber, Alexandra Calmy, et al.
Pageof 42